Abaxis to Present at 2011 Morgan Stanley Global Healthcare Unplugged Conference

UNION CITY, Calif., Sept. 8, 2011 /PRNewswire/ — Abaxis, Inc.
(NasdaqGS: ABAX), a medical products company manufacturing
point-of-care blood analysis systems, announced today that Clint
Serverson, chief executive officer, will present at 2011
Morgan Stanley Global Healthcare Unplugged Conference on Tuesday,
September 13, 2011 at 10:20 a.m. ET at the Grand Hyatt New
York.

About AbaxisAbaxis develops, manufactures, markets and sells
portable blood analysis systems for use in any veterinary or human
patient-care setting to provide clinicians with rapid blood
constituent measurements. The system consists of a compact,
5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the
chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The
system can be operated with minimal training and performs multiple
routine tests on whole blood, serum or plasma samples. The
system provides test results in less than 12 minutes with the
precision and accuracy equivalent to a clinical laboratory
analyzer. The veterinary business also provides to the animal
health and research market a line of hematology instruments for
point-of-care complete blood counts (CBC), a specialty instrument
to screen for and detect clotting disorders and to measure equine
fibrinogen levels, a handheld instrument for the rapid assessment
of certain critical care tests and rapid point-of-care tests for
Heartworm infections in dogs, Parvovirus and Giardia. Abaxis
is in the final stages of building a full-service laboratory
testing facility for veterinarians, focusing on specialty and
esoteric testing and analysis. This state-of-the-art
commercial laboratory will be the hub of the Abaxis Veterinary
Reference Laboratories (AVRL).Contact: